Private Banking|Professional Solutions|Investment Management|Investment Banking|About us
Login
Van Lanschot Kempen Logo
  • Solutions
  • Sectors
  • Careers
Van Lanschot Kempen Logo
Login

All transactions

November 2023
Amvest logo klein
Financial Adviser
€135 million
U.S. Private Placement
December 2023
wdp
Joint Global Coordinator and Joint Bookrunner
€300 million
Accelerated Bookbuild Offering
November 2023
montea Logo
Joint Global Coordinator & Joint Bookrunner
€126 million
Accelerated Bookbuild Offering
November 2023
galapagos
Financial Adviser
€170 million
Sale of Jyseleca business to Alfasigma
October 2023
Cantargia logo
Joint Global Coordinator                            & Joint Bookrunner
SEK 59.3 million
Directed Share Issue
October 2023
transaction logo image
Joint Global Coordinator                        & Joint Lead Bookrunner
NOK 505 million
Accelerated Bookbuild Offering
October 2023
transaction logo image
Sole Financial Adviser
€260 million
Green Loan
October 2023
synact pharma
Sole Financial Adviser
SEK 120 million
Structured Equity with Warrants
October 2023
transaction logo image
Financial Adviser
Undisclosed
Acquisition of Novec GmbH
October 2023
transaction logo image
Joint Bookrunner
€167 million
Accelerated Bookbuild Offering
September 2023
DHG
Sole Financial Adviser
€625 million
Green Loan
September 2023
transaction logo image
Adviser
€500 million
Proposed investment in Stedin Groep
August 2023
merus
Lead manager
USD 173 million
Capital Increase
July 2023
argenx
Manager
USD 1.3 billion
Capital Increase
July 2023
nsi
Sole Financial Adviser
€65 million
Secured Term Loan Extension
June 2023
RED company logo
Joint Venture
Undisclosed
Sole Financial Adviser
June 2023
vicore pharma
Joint Bookrunner
SEK 500 million
Capital increase
June 2023
transaction logo image
Financial Adviser
USD 182 million
Secondary sell-down
May 2023
transaction logo image
Joint Global Coordinator & Joint Bookrunner
€25.0 million
Accelerated Bookbuild Offering
May 2023
TINC logo
Sole Financial Adviser
Undisclosed
Joint Venture
April 2023
terrapay
Financial Adviser
>USD 100 million
Series B funding round
April 2023
sequana medical
Joint Global Coordinator & Joint Bookrunner
€ 15.8 million
Accelerated Bookbuild Offering
April 2023
zealand
Lead Manager
DKK 1.5 billion
Accelerated Bookbuild Offering
March 2023
transaction logo image
Sole Financial Adviser
€ 14 million
Series B funding round
March 2023
transaction logo image
Financial Advisor, Capital Markets Advisor & Placement Agent
USD 220m
PIPE USD 91 million
Feb 2023
curevac
Lead Manager
USD 250 million
US Public Offering
Jan 2023
Powerfield logo
Sole Financial Adviser
circa € 500 million
Structured Equity and Senior Debt Financing
Dec 2022
gensight
Sole Financial Adviser
€ 12.0 million
Convertible Note Issuance
Dec 2022
hansa
Joint Global Coordinator & Joint Bookrunner
SEK 416 million
PIPE
Dec 2022
nsi
Sole Financial Adviser
€50 million
Term Loan Extension
Dec 2022
synact pharma
Joint Global Coordinator & Joint Bookrunner
SEK 80 million
Directed Share Issue via PIPE
Dec 2022
synact pharma
Sole Financial Adviser
SEK 191 million
Acquisition of TXP Pharma
Dec 2022
vicore pharma
Joint Bookrunner
SEK 200 million
Accelerated Bookbuild Offering
Dec 2022
biovica
Joint Bookrunner
SEK 148 million
Guaranteed Rights Issue
Dec 2022
catena
Joint Global Coordinator & Joint Bookrunner
SEK 1,642 million
Accelerated Bookbuild Offering
Dec 2022
molecular partners
Sole Block Placing Agent
1.3 million shares
Block Trade in Molecular Partner Shares
Nov 2022
gensight
Sole Financial Adviser
€ 35.0 million
Secures a credit facility from the European Investment Bank
Nov 2022
izicap
Sole Financial Adviser
€ 15.0 million
Secures venture debt funding from the European Investment Bank
Oct 2022
brane
Joint Global Coordinator & Joint Bookrunner
SEK 170 million
Accelerated Bookbuild Offering
Oct 2022
wdp
Joint Global Coordinator & Joint Bookrunner
€ 300 million
Accelerated Bookbuild Offering
Oct 2022
zealand
Co-Lead Manager
DKK 786 million
Accelerated Bookbuild Offering
Sep 2022
great grey investments
Sole Financial Adviser
Development Financing for The Ensemble
Sep 2022
wdp
Joint Bookrunner
€ 61.5 million
Sale of existing shares via club deal
Sep 2022
HAL Investments
Sole Financial Broker
€ 4,332 million
The acquisition of all Boskalis issued and outstanding shares
Sep 2022
vastned
Sole Financial Adviser
€ 200 million
Extension of Credit Facilities
Aug 2022
mendus
Sole Financial Adviser
SEK 250 million
Convertible Bonds & Shareholder commitment
Aug 2022
Sanquin Health Solutions
Sole Financial Advisor
Sanquin Health Solutions selling its reagents branch to the Dutch Gilde Healthcare
Jul 2022
amvest
Sole Financial Adviser
€ 450 million
Sustainability Linked Unsecured Revolving Credit Facility
Jul 2022
BioInvent
Joint Global Coordinator
SEK 299 milion
Directed share issue via club deal
Jul 2022
Citymall Almere July 2022
Sole Financial Adviser
€ 156 million
Acquisition of Almere Centrum
Jun 2022
abliva
Sole Global Coordinator
SEK 200 million
PIPE Rights Issue
Jun 2022
aedifica
Joint Global Coordinator & Joint Bookrunner
€ 254 million
Accelerated Bookbuild Offering
May 2022
synact pharma
Joint Global Coordinator & Joint Bookrunner
SEK 150 million
Rights Issue
Mar 2022
graydon
Sole Financial Adviser
Undisclosed
Sale to Creditsafe
Mar 2022
catena
Financial Adviser
SEK 2.17 billion
Directed Share Issue to WDP
Mar 2022
innosign
Sole Financial Adviser
Capital Increase & Spin-Out
Mar 2022
argenx
Co-Manager
USD 700 million
Global Accelerated Bookbuild Offering
Feb 2022
ctp
Sole Financial Adviser
€ 1,226 million
Public takeover of Deutsche Industrie REIT-AG
Jan 2022
aquila capital
Sole Financial Adviser
€ 330 million
Non-listed equity raise of European Logistics Fund
Jan 2022
molecular partners
Sole Block Placing Agent
1.4m shares
Block Trade in Molecular Partners Shares
Jan 2022
das
Sole Financial Adviser
Sale of Cannock-EDR Holding B.V.

All transactions

See all transactions made throughout the years.
All transactions in 2023

All transactions in 2022

All transactions in 2021

All transactions in 2020

All transactions in 2019

All transactions in 2018

All transactions in 2017

All transactions in 2016

All transactions in 2015

All transactions in 2014

All transactions in 2013

Fully focused on your future

Private Banking
  • Offices
  • Entrepreneurs
  • Healthcare
  • Executives
  • Business professionals
  • Wealth management
  • Conditions
  • Private Banking - Belgium
  • Private Banking - Switzerland
Professional Solutions
Investment Management
Investment Banking
© Van Lanschot Kempen NV 2023About usSecurity and fraud awarenessPrivacy & cookiesDisclaimer